Bayer Pharmaceuticals Corporation Pharmaceutical Division, West Haven, CT; Including Employees of Bayer Pharmaceuticals Corporation, Pharmaceutical Division, West Haven, CT, Located in the Following States: TA-W-53,129QQ Delaware, TA-W-53,129RR Iowa, TA-W-53,129SS Maine, TA-W-53,129TT Nebraska, TA-W-53,129UU Vermont, TA-W-53,129VV District Of Columbia, 15644 [E5-1355]
Download as PDF
<![CDATA[
15644
Federal Register / Vol. 70, No. 58 / Monday, March 28, 2005 / Notices
Form Number: OJP FORM 4587/1.
Office of Justice Programs.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: State, local or tribal
government. Other: Federal government,
individuals or households, not-for-profit
institutions. The Uniform
Administrative Requirements for Grants
and Cooperative Agreements—28 CFR
part 66, and OMB Circular A–100—
authorizes the Department of Justice to
collect information from grantees to
report on project activities and
accomplishments. Grantees that are
recipients of a discretionary grant, as
well as some formula grants, are
required by OJP to report project
activities and accomplishments by
submitting Categorical Assistance
Progress Reports. These reports are
expected to include details regarding
the stage of project development and
data regarding accomplishments to date.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that 10,
366 respondents will take
approximately two hours to complete
each semi-annual submission of the
Categorical Assistance Progress Report
for a total of four hours annually per
grantee.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated
44,164 total annual burden hours
associated with this collection.
If additional information is required
contact: Brenda E. Dyer, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: March 22, 2005.
Brenda E. Dyer,
Department Clearance Officer, Department of
Justice.
[FR Doc. 05–6020 Filed 3–25–05; 8:45 am]
BILLING CODE 4410–18–P
VerDate jul<14>2003
15:12 Mar 25, 2005
Jkt 205001
The amended notice applicable to
TA–W–53,129 is hereby issued as
follows:
DEPARTMENT OF LABOR
Employment and Training
Administration
[TA–W–53,129]
Bayer Pharmaceuticals Corporation
Pharmaceutical Division, West Haven,
CT; Including Employees of Bayer
Pharmaceuticals Corporation,
Pharmaceutical Division, West Haven,
CT, Located in the Following States:
TA–W–53,129QQ Delaware, TA–W–
53,129RR Iowa, TA–W–53,129SS
Maine, TA–W–53,129TT Nebraska, TA–
W–53,129UU Vermont, TA–W–53,129VV
District Of Columbia
Amended Notice of Certification
Regarding Eligibility To Apply for
Worker Adjustment Assistance
In accordance with Section 223 of the
Trade Act of 1974 (19 U.S.C. 2273) the
Department of Labor issued a Notice of
Certification Regarding Eligibility to
Apply for Worker Adjustment
Assistance on October 24, 2003,
applicable to workers of Bayer
Pharmaceuticals Corporation,
Pharmaceutical Division, West Haven,
Connecticut. The notice was published
in the Federal Register on November 28,
2003 (68 FR 66878). The certification
was amended on February 1, 2005 to
include workers of the West Haven,
Connecticut facility of the subject firm
located in many states throughout the
United States. The notice was published
in the Federal Register on February 22,
2005 (70 FR 8636–8637).
At the request of the State agency, the
Department reviewed the certification
for workers of the subject firm. New
information shows that workers were
separated involving employees of the
West Haven, Connecticut facility of
Bayer Pharmaceuticals Corporation,
Pharmaceutical Division located in the
above mentioned states. These
employees provided sales support
services for the production of
pharmaceutical products at the West
Haven, Connecticut location of the
subject firm.
Based on these findings, the
Department is amending this
certification to include employees of the
West Haven, Connecticut facility of
Bayer Pharmaceuticals Corporation,
Pharmaceutical Division, located in the
above mentioned states.
The intent of the Department’s
certification is to include all workers of
Bayer Pharmaceuticals Corporation,
Pharmaceutical Division, West Haven,
Connecticut, who were adversely
affected by increased imports.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
‘‘All workers of Bayer Pharmaceuticals
Corporation, Pharmaceutical Division, West
Haven, Connecticut (TA–W–53,129),
including employees of Bayer
Pharmaceuticals Corporation, Pharmaceutical
Division, West Haven, Connecticut, located
in the following states: Delaware (TA–W–
53,129QQ), Iowa (TA–W–53,129RR), Maine
(TA–W–53,129SS), Nebraska (TA–W–
53,129TT), Vermont (TA–W–53,129UU) and
District of Columbia (TA–W–53,129VV), who
became totally or partially separated from
employment on or after October 1, 2002,
through October 24, 2005, are eligible to
apply for adjustment assistance under
Section 223 of the Trade Act of 1974.’’
Signed at Washington, DC this 14th day of
March 2005.
Richard Church,
Certifying Officer, Division of Trade
Adjustment Assistance.
[FR Doc. E5–1355 Filed 3–25–05; 8:45 am]
BILLING CODE 4510–30–P
DEPARTMENT OF LABOR
Employment and Training
Administration
Investigations Regarding Certifications
of Eligibility To Apply for Worker
Adjustment Assistance
Petitions have been filed with the
Secretary of Labor under Section 221(a)
of the Trade Act of 1974 (‘‘the Act’’) and
are identified in the Appendix to this
notice. Upon receipt of these petitions,
the Director of the Division of Trade
Adjustment Assistance, Employment
and Training Administration, has
instituted investigations pursuant to
Section 221(a) of the Act.
The purpose of each of the
investigations is to determine whether
the workers are eligible to apply for
adjustment assistance under Title II,
Chapter 2, of the Act. The investigations
will further relate, as appropriate, to the
determination of the date on which total
or partial separations began or
threatened to begin and the subdivision
of the firm involved.
The petitioners or any other persons
showing a substantial interest in the
subject matter of the investigations may
request a public hearing, provided such
request is filed in writing with the
Director, Division of Trade Adjustment
Assistance, at the address shown below,
not later than April 7, 2005.
Interested persons are invited to
submit written comments regarding the
subject matter of the investigations to
the Director, Division of Trade
Adjustment Assistance, at the address
E:\FR\FM\28MRN1.SGM
28MRN1
]]>Agencies
[Federal Register Volume 70, Number 58 (Monday, March 28, 2005)]
[Notices]
[Page 15644]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-1355]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF LABOR
Employment and Training Administration
[TA-W-53,129]
Bayer Pharmaceuticals Corporation Pharmaceutical Division, West
Haven, CT; Including Employees of Bayer Pharmaceuticals Corporation,
Pharmaceutical Division, West Haven, CT, Located in the Following
States: TA-W-53,129QQ Delaware, TA-W-53,129RR Iowa, TA-W-53,129SS
Maine, TA-W-53,129TT Nebraska, TA-W-53,129UU Vermont, TA-W-53,129VV
District Of Columbia
Amended Notice of Certification Regarding Eligibility To Apply for
Worker Adjustment Assistance
In accordance with Section 223 of the Trade Act of 1974 (19 U.S.C.
2273) the Department of Labor issued a Notice of Certification
Regarding Eligibility to Apply for Worker Adjustment Assistance on
October 24, 2003, applicable to workers of Bayer Pharmaceuticals
Corporation, Pharmaceutical Division, West Haven, Connecticut. The
notice was published in the Federal Register on November 28, 2003 (68
FR 66878). The certification was amended on February 1, 2005 to include
workers of the West Haven, Connecticut facility of the subject firm
located in many states throughout the United States. The notice was
published in the Federal Register on February 22, 2005 (70 FR 8636-
8637).
At the request of the State agency, the Department reviewed the
certification for workers of the subject firm. New information shows
that workers were separated involving employees of the West Haven,
Connecticut facility of Bayer Pharmaceuticals Corporation,
Pharmaceutical Division located in the above mentioned states. These
employees provided sales support services for the production of
pharmaceutical products at the West Haven, Connecticut location of the
subject firm.
Based on these findings, the Department is amending this
certification to include employees of the West Haven, Connecticut
facility of Bayer Pharmaceuticals Corporation, Pharmaceutical Division,
located in the above mentioned states.
The intent of the Department's certification is to include all
workers of Bayer Pharmaceuticals Corporation, Pharmaceutical Division,
West Haven, Connecticut, who were adversely affected by increased
imports.
The amended notice applicable to TA-W-53,129 is hereby issued as
follows:
``All workers of Bayer Pharmaceuticals Corporation,
Pharmaceutical Division, West Haven, Connecticut (TA-W-53,129),
including employees of Bayer Pharmaceuticals Corporation,
Pharmaceutical Division, West Haven, Connecticut, located in the
following states: Delaware (TA-W-53,129QQ), Iowa (TA-W-53,129RR),
Maine (TA-W-53,129SS), Nebraska (TA-W-53,129TT), Vermont (TA-W-
53,129UU) and District of Columbia (TA-W-53,129VV), who became
totally or partially separated from employment on or after October
1, 2002, through October 24, 2005, are eligible to apply for
adjustment assistance under Section 223 of the Trade Act of 1974.''
Signed at Washington, DC this 14th day of March 2005.
Richard Church,
Certifying Officer, Division of Trade Adjustment Assistance.
[FR Doc. E5-1355 Filed 3-25-05; 8:45 am]
BILLING CODE 4510-30-P
